Health & Fitness
Health and Fitness
Health and Fitness
Wed, November 30, 2011Tue, November 29, 2011Mon, November 28, 2011Sun, November 27, 2011Fri, November 25, 2011Thu, November 24, 2011Wed, November 23, 2011Tue, November 22, 2011Mon, November 21, 2011Sun, November 20, 2011Fri, November 18, 2011Thu, November 17, 2011Wed, November 16, 2011The Law Firm of Levi &;; Korsinsky Notifies Investors With Losses on Their Investment in Hospira, Inc. of Class Actio
Published in Health and Fitness on Tuesday, November 22nd 2011 at 14:31 GMT by Market Wire
November 22, 2011 17:24 ET
The Law Firm of Levi & Korsinsky Notifies Investors With Losses on Their Investment in Hospira, Inc. of Class Action Lawsuit and the Deadline of January 20, 2012 to Seek a Lead Plaintiff Position
NEW YORK, NY--(Marketwire - Nov 22, 2011) - Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Northern District of Illinois on behalf of purchasers of Hospira, Inc. ("Hospira" or the "Company") (
For more information, click here: [ http://zlk.9nl.com/hospira-hsp ].
The complaint alleges that throughout the Class Period, defendants issued materially false and misleading statements regarding the Company's business and financial results. Specifically, defendants failed to disclose that: (a) the Company suffered from extensive quality control issues which undermined both the viability of and the supposed financial savings that would be generated by Project Fuel, a Company program designed to optimize the Company's operations and increase shareholder value; (b) the Company was unable to remedy problems identified in FDA Warning Letters related to Hospira's infusion pumps, quality control deficiencies, and manufacturing weaknesses; (c) Hospira misstated and lacked a reasonable basis for its revenue guidance for 2010 and 2011; and (d) as a result of the foregoing, defendants' statements regarding the Company's financial performance and expected earnings were false and misleading.
In reaction to the Company's negative results, on October 18, 2011 Hospira common stock fell $7.85 per share to close at $29.51 per share.
If you suffered a loss in Hospira stock you have until January 20, 2012 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. To obtain additional information, contact Joseph E. Levi, Esq. either via email at [ jlevi@zlk.com ] or by telephone at (877) 363-5972, or visit [ http://www.zlk.com/hospira-hsp.html ].
Levi & Korsinsky has expertise in prosecuting investor securities litigation and extensive experience in actions involving financial fraud and represents investors throughout the nation, concentrating its practice in securities and shareholder litigation. Attorney advertising. Prior results do not guarantee similar outcomes.
